AML92 protocol

Preferred Label : AML92 protocol;

MeSH note : chemotherapy protocol consisting of enocitabine, all-trans retinoic acid, and daunorubicin; used against acute promyelocytic leukemia;

Is substance : O;

Details

Origin ID

C107288;

UMLS CUI

C0663905;

MeSH term(s) associated for indexing
- antineoplastic combined chemotherapy protocols [MeSH Descriptor]
- cytarabine [MeSH Descriptor]
- daunorubicin [MeSH Descriptor]
- tretinoin [MeSH Descriptor]
Record concept(s)
- AML92 protocol [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients